Access brought to you by: LOCKSS

Cardiology Clinical Trials

Novel Interventional Approaches are Effective against Resistant Hypertension
Vitamin E and C Supplements Do Not Reduce Long-Term Cardiovascular Risk
Tailored Clopidogrel Dosing Reduces Adverse Events in Patients with Clopidogrel Resistance Undergoing PCI
I-PRESERVE Trial Fails to Find Clinical Benefit of Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
Intensified Medical Therapy Does Not Appear to Benefit Elderly Heart Failure Patients
Fish Oil Supplementation—But Not Statin Therapy—Reduces Death in Heart Failure
PCI is a “Reasonable” Strategy for Diabetic Patients with Multivessel Disease: The CARDia Trial
Promise and Problems Emerge for Oral Investigative Factor Xa Drug in Treating Acute Coronary Syndrome
Celecoxib Cross Trial Safety Analysis
The ENHANCE Study: What Do We Know Now?

Pages